cancer-congress-2019-keynote

2 / 4

Cancer Congress 2019 Journal of Cancer Immunology &Therapy | Volume 2
Page 12
July 22-23, 2019 | Brussels, Belgium
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
CANCER SCIENCE AND THERAPY
2nd Global Congress on
STUDY OF RATIONALITY OF
PROMOTIONAL DRUG LITERATURE
RECEIVED AT A CANCER HOSPITAL
Introduction: The drug promotional literature (DPL) of the pharmaceutical
companies is important sources of drug information. However, these DPLs
are inaccurate and of poor educational value. Hence, authors planned this
study to evaluate the DPLs of anticancer drugs for accuracy, consistency and
validity of the information presented in it, using World Health Organization
(WHO) ethical criteria for medicinal drug promotion.
Materials & Methods: This observational study was conducted over six
month’s duration. The DPLs were collected from OPD at Jeevan Jyoti Cancer
Hospital, Jalgaon and evaluated in Department of Pharmacology in a Medi-
cal Institute in India. The literature was evaluated based on the WHO ethical
criteria for drug promotion.
Results: Only 6% of the DPLs fulfilled all WHO criteria and 53% of DPLs were
of anticancer drugs. 38% DPLs did not have any brief prescription informa-
tion about the promoted drug. Majority (92%) of DPLs claimed about the ef-
ficacy of product. Out of 132 references, 24% were not retrieved. Brochures
presenting irrelevant pictures were 48% whereas statistically significant dif-
ference was found between the availability of printed side effects, precau-
tions, contra-indications, warnings, drug interactions, number of quoted ref-
erences before 2014 and brief prescription information on DPLs of anticancer
and other drugs groups with p-value <0.05.
Conclusion: Pharmaceutical industries did not follow the WHO guidelines
while promoting their products and to reduce this problem, government
regulatory bodiesmust play a pre-emptive rolewhere code of ethics is failing.
Chaudhari Nitin Laxman, J Cancer Immunol Ther 2019, Volume 2
Chaudhari Nitin Laxman has completed his Doc-
tor of Medicine (DM) from prestigious Gujarat
Cancer and Research Institute a leading Cancer
Hospital of India. He was a well accomplished
student and had secured Gold medal for Doctor
of Medicine examination fromGujarat University.
He is a consultant at Jeevan Jyoti Cancer Hospital
Jalgaon. His special interests include breast can-
cer and lymphoma. His social activities include
free service to one of the most remote, backward
and tribal areas of India like Nandurbar district.
Chaudhari Nitin Laxman
Jeevan Jyoti Cancer Hospital, India
BIOGRAPHY